Pediatric Infection-Induced SARS-CoV-2 Seroprevalence Increases and Seroprevalence by Type of Clinical Care—September 2021 to February 2022 | Zendy

Kristie E.N. Clarke | Zendy; Yun Kim | Zendy; Jefferson M. Jones | Zendy; Adam Lee | Zendy; Yangyang Deng | Zendy; Elise Nycz | Zendy; Ronaldo Iachan | Zendy; Adi V. Gundlapalli | Zendy; Adam MacNeil | Zendy; Aron J. Hall | Zendy

Open Access

Pediatric Infection-Induced SARS-CoV-2 Seroprevalence Increases and Seroprevalence by Type of Clinical Care—September 2021 to February 2022

Author(s) -

Kristie E.N. Clarke,

Yun Kim,

Jefferson M. Jones,

Adam Lee,

Yangyang Deng,

Elise Nycz,

Ronaldo Iachan,

Adi V. Gundlapalli,

Adam MacNeil,

Aron J. Hall

Publication year - 2022

Publication title -

the journal of infectious diseases

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 2.69

H-Index - 252

eISSN - 1537-6613

pISSN - 0022-1899

DOI - 10.1093/infdis/jiac423

Subject(s) - seroprevalence , medicine , confidence interval , multivariate analysis , epidemiology , pediatrics , demography , immunology , serology , antibody , sociology

Trends in estimates of US pediatric SARS-CoV-2 infection-induced seroprevalence from commercial laboratory specimens may overrepresent children with frequent health care needs. We examined seroprevalence trends and compared seroprevalence estimates by testing type and diagnostic coding.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom

About

About Careers Publisher Partners Contact Us Our institutional solutions Get Organisational Trial or Quote

Learn

FAQs Blog Terms of Use Privacy Policy

Download the Zendy App

Discover

Explore

Home ZAIA Blog